Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
OPERATING EXPENSES        
General and administrative $ 1,203,020 $ 2,236,325 $ 6,523,996 $ 8,934,037
Research and development 387,564 5,487,056 2,912,094 17,079,335
Restructuring and impairment 1,222,592 0 1,229,319 0
TOTAL OPERATING EXPENSES 2,813,176 7,723,381 10,665,409 26,013,372
LOSS FROM OPERATIONS (2,813,176) (7,723,381) (10,665,409) (26,013,372)
OTHER INCOME (EXPENSE)        
Interest expense (122) (2,693) (3,206) (8,828)
Interest income 162,924 106,710 457,349 147,302
Loss on issuance of common stock and warrants (660) 0 (1,312,212) 0
Change in fair value of warrant liabilities 810,895 0 2,241,246 0
Other income (expense), net 19,027 (12,524) (78,787) (172,736)
Total other income (expense), net 992,064 91,493 1,304,390 (34,262)
NET LOSS $ (1,821,112) $ (7,631,888) $ (9,361,019) $ (26,047,634)
BASIC LOSS PER SHARE (in dollars per share) $ (0.66) $ (4.73) $ (4.57) $ (16.08)
DILUTED LOSS PER SHARE (in dollars per share) $ (0.66) $ (4.73) $ (4.57) $ (16.08)
WEIGHTED AVERAGE SHARES OUTSTANDING:        
BASIC (in shares) 2,757,576 1,614,156 2,046,477 1,620,344
DILUTED (in shares) 2,757,576 1,614,156 2,046,477 1,620,344